FibroGen Inc (FGEN) support and resistance · rev $29.6M
FibroGen Inc (FGEN) is a biotechnology company listed on NASDAQ.
This page maps FibroGen Inc (FGEN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FGEN revenue for 2024-12-31 was $29.6M. Net income was -$47.6M. Revenue was down 36.7% from 2023-12-31 to 2024-12-31. FGEN currently screens at market cap $39.3M.
FGEN currently screens at market cap $39.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FGEN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FGEN quote page for the session range and the stock page for the full model.
Not investment advice.